What is the Impact Factor of Chinese Journal of Lung Cancer?

The journal Chinese Journal of Lung Cancer is indexed in Web of Science (SCIE, quartile Q1) with official metrics continually updated on ImpaQ.

Is Chinese Journal of Lung Cancer indexed in Web of Science or Scopus?

Yes, Chinese Journal of Lung Cancer is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.307 (Q3) and an H-index of 24.

Who publishes Chinese Journal of Lung Cancer and what is the Article Processing Charge (APC)?

Chinese Journal of Lung Cancer is published by Chinese Anticancer Association. The estimated Article Processing Charge (APC) is approximately $2,524 USD, subject to institutional waivers and corresponding author affiliations.

WoS SCIE Q1Scopus Q3SCImago #16,949Diamond OADomestic Journal

Chinese Journal of Lung Cancer

Identifier (ISSN):1009-3419(Print)/1999-6187(Online)

•

Publisher:Chinese Anticancer Association

Clarivate JCR Index Advisory: Not Indexed in Latest JCR

Official Website Submission Portal Compare

Clarivate Impact Factor (IF 2024)

N/A

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

Impact Factor Trend

Clarivate IF trend for Chinese Journal of Lung Cancer

WoS Q1

Annual Impact Factor Metric

Current (2025):0

Scopus SJR & RankScopus Q3

0.307

#16,949

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

24 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessDiamond OA

3articles/year

0% Gold OA•0% Original Research

Aims & Scope

Chinese Journal of Lung Cancer(CJLC, pISSN 1009-3419, eISSN 1999-6187), a monthly Open Access journal, is hosted by Chinese Anti-Cancer Association, Chinese Antituberculosis Association, Tianjin Medical University General Hospital. CJLC was indexed in DOAJ, EMBASE/SCOPUS, Chemical Abstract(CA), CSA-Biological Science, HINARI, EBSCO-CINAHL,CABI Abstract, Global Health, CNKI, etc. Editor-in-Chief: Professor Qinghua ZHOU.

Topics Covered (Recognized by AI)

Medicine99.1%Internal medicine97.4%Pathology93.7%Biology92.3%Oncology90.9%Lung cancer90.3%Genetics82.7%Cancer66.9%Chemistry51.5%Surgery50.8%Biochemistry47.5%Philosophy37.6%Linguistics36.5%Lung35.7%Cancer research34.5%Immunology31.9%Radiology30.6%Gene30.3%Chemotherapy21.2%

Primary Research Areas

Medicine Pulmonary and Respiratory Medicine

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

2 year

2025Latest

IF0

Articles / Year—

Total Citations—

2010

IF—

Articles / Year3

Total Citations0

Year	Impact Factor	Articles / Year	Total Citations
2025	0	—	—
2010	—	3	0

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #16,949Scopus Q3SCImago Profile

Scopus Coverage:2002-2025

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q3

0.307

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

1.14

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,524 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations382

3-Year Documents339

Citable Documents339

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ3

Pulmonary and Respiratory MedicineQ3

Cancer ResearchQ4

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

Updating

Minor Category (Specific Field):

Updating

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Chinese Journal of Lung Cancer (ISSN: 1009-3419) is a peer-reviewed international scholarly journal in the field of Medicine, published by Chinese Anticancer Association in China. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 0.307 (Q3), an H-index of 24.

The journal enforces rigorous peer evaluation with an annual output of approximately 3 scientific articles. In terms of accessibility and author fees, it operates under the Diamond OA model with an estimated APC of $2,524 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.